pharmanewsintel

covers the latest news and research on pharmaceutical technology, clinical trials, supply chain, and more. Part of Xtelligent Media

[pharmanewsintel @pharmanewsintel]

[New Article] In the ever-changing oncology landscape, cross-benefit drug management tackles challenges, reduces costs, and shapes the future of care.
Sponsored by @Optum https://t.co/1oSXVpT9G7

[pharmanewsintel @pharmanewsintel]

[New Article] Optum's Specialty Fusion enables a 60% auto-approval rate within 10 minutes, significantly streamlining specialty and oncology authorizations. Sponsored by @Optum https://t.co/aJfBpEX2eW

[pharmanewsintel @pharmanewsintel]

[New Article] Embracing cross-benefit strategies in specialty drug management enhances cost control and quality care and breaks free from the specialty drug tunnel. Sponsored by @Optum https://t.co/YpWDBhpzDH

[pharmanewsintel @pharmanewsintel]

[Executive Viewpoint] Digital transformation is key to harnessing the potential of data generated by life sciences organizations using AI, machine learning, and emerging technologies. https://t.co/4u3ZwVjXp3

[pharmanewsintel @pharmanewsintel]

Reuters exclusive reporting found that two-thirds of patients discontinue using weight-loss drugs before achieving lasting health improvements.
#weightloss #wegovy #obesity
https://t.co/hRrrY3iN9s

[pharmanewsintel @pharmanewsintel]

Monoclonal antibodies have unleashed the power of precision medicine for various medical conditions.
#monoclonalantibodies #covid19 #infectiousdiseases

https://t.co/ST7hB1D0tU

[pharmanewsintel @pharmanewsintel]

In a landmark event, the @US_FDA approved the first-ever over-the-counter, nonprescription oral birth control, Opill. (@PerrigoCompany)
#pharma #fda #reproductivehealth #contraception

https://t.co/tyj13As3IX

[pharmanewsintel @pharmanewsintel]

@GSK recently launched a new platform for adult vaccine tracking as part of its CoIMMUNITY Initiative for improving adult vaccination.
https://t.co/3sUOpvtarA

[pharmanewsintel @pharmanewsintel]

In light of recent overdose trends, the White House has issued a national response plan that addresses the risks of fentanyl and xylazine.
#fentanyl #xylazine #harmreduction

https://t.co/DyLKFMOciZ

[pharmanewsintel @pharmanewsintel]

[#PharmaLifeSci2023] Join us today for the session "The Future of Specialty #Pharmacy", which focuses on the shifting landscape of #SpecialtyMedications, the evolving demands on #SpecialtyPharmacies, and much more!
Sponsored by @AdvisoryBd
https://t.co/eHYlBLoHms

[pharmanewsintel @pharmanewsintel]

Drinking water in the US may contain one to nine PFAS chemicals that can have long-term, significant health implications.

Written by @veronicaa_salib
#water #PFAS
@EPA @EPAwater
https://t.co/wV91Uwu6Jb

[pharmanewsintel @pharmanewsintel]

[Upcoming Event] Join us for the session "The Future of Specialty #Pharmacy", which focuses on the shifting landscape of #SpecialtyMedications, the evolving demands on #SpecialtyPharmacies, and much more!
Sponsored by Advisory Board
https://t.co/eHYlBLo9wU

[pharmanewsintel @pharmanewsintel]

After reviewing the supplemental Biologics License Application, the FDA granted Biogen and Eisai US’s Lequembi traditional approval.
#fda #alzheimers #drugdevelopment
https://t.co/tpSOnP3VzK

[pharmanewsintel @pharmanewsintel]

Weight loss drugs can be critical in obesity management; however, nuances and complexities indicate the need for additional guidance.

Written by @Veronicaa_salib
#weightloss #ozempic #semaglutide
https://t.co/waoO33lYvn

[pharmanewsintel @pharmanewsintel]

Adding to a series of frozen fruit recalls linked to hepatitis A, the FDA has added some frozen pineapples to the recall list due to listeria contamination.
#fda #frozenfruits #infectiousdiseases
https://t.co/X5dtn7T8oM

[pharmanewsintel @pharmanewsintel]

Reteratrutide, Eli Lilly and Company's newest experimental weight loss drug, helps patients achieve a 17.5% weight reduction at 24 weeks in a phase 2 clinical trial.
#weightmanagement #clinicalresearch
https://t.co/Xyi9QcNpRU

[pharmanewsintel @pharmanewsintel]

Last week, the FDA launched a pilot program aimed at sponsors of some oncology drugs to reduce the risk of cancer biomarker testing.

https://t.co/Xa5HRJZE8N

[pharmanewsintel @pharmanewsintel]

The FDA recently approved a new class of pediatric medications, empagliflozin, to treat type 2 diabetes, adding an alternative to metformin, the only previously available oral medicine.
#fda #medicine #pediatrics #t2d
https://t.co/cn8RD5dsLs

[pharmanewsintel @pharmanewsintel]

Just months after a series of frozen fruit recalls, the @US_FDA has announced additional recalls on other frozen fruit for potential hepatitis A contamination

#recall #publichealth #infectiousdisease #CDC #FDA #medEd #medTwitter #hepatitisA #contamination
https://t.co/0Nshoob3MY

[pharmanewsintel @pharmanewsintel]

[Upcoming #Event] Last Chance to register for this multi-session event with #LifeScience partners who delve into the benefits of #CloudBased platforms, improving #data accessibility, & more! | 1st session starts on June 21 @ 11AM ET
https://t.co/TV2N0LWLyU